Literature DB >> 20619301

MicroRNAs: synthesis, mechanism, function, and recent clinical trials.

Fazli Wahid1, Adeeb Shehzad, Taous Khan, You Young Kim.   

Abstract

MicroRNAs (miRNAs) are a class of small, endogenous RNAs of 21-25 nucleotides (nts) in length. They play an important regulatory role in animals and plants by targeting specific mRNAs for degradation or translation repression. Recent scientific advances have revealed the synthesis pathways and the regulatory mechanisms of miRNAs in animals and plants. miRNA-based regulation is implicated in disease etiology and has been studied for treatment. Furthermore, several preclinical and clinical trials have been initiated for miRNA-based therapeutics. In this review, the existing knowledge about miRNAs synthesis, mechanisms for regulation of the genome, and their widespread functions in animals and plants is summarized. The current status of preclinical and clinical trials regarding miRNA therapeutics is also reviewed. The recent findings in miRNA studies, summarized in this review, may add new dimensions to small RNA biology and miRNA therapeutics.
Copyright © 2010 Elsevier B.V. All rights reserved.

Mesh:

Substances:

Year:  2010        PMID: 20619301     DOI: 10.1016/j.bbamcr.2010.06.013

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  280 in total

1.  Translational Regulation of the Mitochondrial Genome Following Redistribution of Mitochondrial MicroRNA in the Diabetic Heart.

Authors:  Rajaganapathi Jagannathan; Dharendra Thapa; Cody E Nichols; Danielle L Shepherd; Janelle C Stricker; Tara L Croston; Walter A Baseler; Sara E Lewis; Ivan Martinez; John M Hollander
Journal:  Circ Cardiovasc Genet       Date:  2015-09-16

2.  Long non-coding RNA GAS5, by up-regulating PRC2 and targeting the promoter methylation of miR-424, suppresses multiple malignant phenotypes of glioma.

Authors:  Chen Jin; Jie Zhao; Zhi-Ping Zhang; Ming Wu; Jian Li; Ge-Lei Xiao; Bo Liu; Yu-Xiang Liao; Jing-Ping Liu
Journal:  J Neurooncol       Date:  2020-05-29       Impact factor: 4.130

3.  miR-365b-3p inhibits the cell proliferation and migration of human coronary artery smooth muscle cells by directly targeting ADAMTS1 in coronary atherosclerosis.

Authors:  Yunfei Qu; Ning Zhang
Journal:  Exp Ther Med       Date:  2018-09-11       Impact factor: 2.447

4.  MicroRNA-2053 overexpression inhibits the development and progression of hepatocellular carcinoma.

Authors:  Tao Song; Ke Ma; Cui Zhao; Jijin Yang; Jingyu Liu
Journal:  Oncol Lett       Date:  2019-06-20       Impact factor: 2.967

5.  MicroRNA associated with dyslipidemia and coronary disease in humans.

Authors:  Elena Flowers; Bradley E Aouizerat
Journal:  Physiol Genomics       Date:  2013-10-29       Impact factor: 3.107

Review 6.  Translational application of epigenetic alterations: ovarian cancer as a model.

Authors:  Marie E Maradeo; Paul Cairns
Journal:  FEBS Lett       Date:  2011-03-12       Impact factor: 4.124

7.  Differential expression of miR200a-3p and miR21 in grade II-III and grade IV gliomas: evidence that miR200a-3p is regulated by O⁶-methylguanine methyltransferase and promotes temozolomide responsiveness.

Authors:  Yolande Berthois; Christine Delfino; Philippe Metellus; Frederic Fina; Isabelle Nanni-Metellus; Hayat Al Aswy; Victor Pirisi; L'Houcine Ouafik; Françoise Boudouresque
Journal:  Cancer Biol Ther       Date:  2014-04-22       Impact factor: 4.742

Review 8.  MicroRNAs and Transplantation.

Authors:  Zahraa Khan; Manikkam Suthanthiran; Thangamani Muthukumar
Journal:  Clin Lab Med       Date:  2018-12-22       Impact factor: 1.935

Review 9.  Establishing a role for environmental toxicant exposure induced epigenetic remodeling in malignant transformation.

Authors:  Kristen M Humphrey; Sumali Pandey; Jeffery Martin; Tamara Hagoel; Anne Grand'Maison; Joyce E Ohm
Journal:  Semin Cancer Biol       Date:  2018-11-16       Impact factor: 15.707

Review 10.  AUF1 regulation of coding and noncoding RNA.

Authors:  Elizabeth J F White; Aerielle E Matsangos; Gerald M Wilson
Journal:  Wiley Interdiscip Rev RNA       Date:  2016-09-13       Impact factor: 9.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.